C12N 2710/16771
Demonstrated in vivo effect
C12N2710/16771 (Demonstrated in vivo effect) appears on 24 US grants and 33 published applications in this corpus.
Search patents in C12N- Granted patents
- 24
- Published applications
- 33
- Assignees
- 19
- Inventors
- 70
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 5 |
| 2017 | 2 | 2 |
| 2018 | 4 | 3 |
| 2019 | 3 | 3 |
| 2020 | 4 | 0 |
| 2021 | 2 | 3 |
| 2022 | 0 | 2 |
| 2023 | 3 | 6 |
| 2024 | 0 | 1 |
| 2025 | 1 | 3 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Shingles vaccines comprising a TLR9 agonist10 Mar 2026US 12,569,553 B2Dynavax Technologies Corporation
- Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex13 May 2025US 12,296,003 B2Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Antigen variant of Varicella Zoster virus and use thereof9 May 2023US 11,642,408 B2Mogam Institute for Biomedical Research
- Nucleic acid vaccines for varicella zoster virus (VZV)9 May 2023US 11,643,441 B1ModernaTX, Inc.
- Vaccine compositions of herpesvirus envelope protein combinations to induce immune response7 Feb 2023US 11,572,389 B2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Truncated varicella-zoster virus envelope glycoprotein ge24 Jul 2025US 2025/0236646 A1Xiamen Innovax Biotech Co., Ltd.
- Nucleic acid vaccines for varicella zoster virus (vzv)12 Jun 2025US 2025/0188132 A1ModernaTX, Inc.
- Immunogenicity of a cpg-adjuvanted herpes zoster vaccine22 May 2025US 2025/0163105 A1Dynavax Technologies Corporation
- Vaccine compositions of herpesvirus envelope protein combinations to induce immune response15 Aug 2024US 2024/0270796 A1The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Nucleic acid vaccines for varicella zoster virus (vzv)23 Nov 2023US 2023/0374079 A1ModernaTX, Inc.
Most cited
By later US patents
- Nucleic acid vaccines for varicella zoster virus (VZV)33US 11,643,441 B1ModernaTX, Inc. · 2023
- Cationic oil-in-water emulsions12US 9,636,410 B2Glaxosmithkline Biologicals SA · 2017
- Immunostimulatory plasmids10US 10,155,950 B2Bayer Animal Health GmbH · 2018
- Cationic oil-in-water emulsions8US 10,183,074 B2Glaxosmithkline Biologicals SA · 2019
- Cationic oil-in-water emulsions6US 11,167,028 B2Glaxosmithkline Biologicals SA · 2021